Skip to main content

Neurology

Experience cutting-edge neurology clinical trials with Revive Research Institute in Rochester, Michigan, as we strive to pioneer advanced treatment options for individuals with neuro disorders. Join us in our mission to transform lives through groundbreaking research and innovative solutions. Discover novel potential possibilities through our rigorous trials, dedicated to improving the lives of those affected by neurological conditions. Together, let’s pave the way for a brighter future in neurology care.

Epilepsy with Generalized Tonic-clonic Seizures

Tired of dealing with unprovoked seizures?  

Revive Research Institute is conducting a Neurology Clinical trial to help people living with a debilitating condition called Epilepsy with Generalized Tonic-clonic Seizures.

This research study evaluates the safety and efficacy of a study drug. If you or someone you love has been dealing with unprovoked seizures associated with Epilepsy, enrolling in Epilepsy Clinical Research studies in Illinois or Michigan may potentially help.

Age

18 to 75 years of age

Gender

Male and Female

Condition

Epilepsy with Generalized Tonic-Clonic Seizures

Current Status

Recruiting

Multiple Sclerosis

Have Not Experienced Relapse in Past Year But Want Enhanced Benefits? 

If you are being treated for Multiple Sclerosis and have not experienced a relapse in the past year, consider participating in Multiple Sclerosis Clinical Trials near you! Revive Research Institute is conducting Neurology Clinical Trials to investigate the safety and efficacy of an investigational drug that may be able to be more beneficial to people with Multiple Sclerosis.
The purpose of this research study is to evaluate the safety and efficacy of a novel drug. If you or someone you love is undertreatment for Multiple Sclerosis and has not relapsed in the past year enrolling in multiple sclerosis clinical trials may potentially help.

Age

18-45 years of age

Gender

Male and Female

Condition

Multiple Sclerosis

Current Status

Recruiting

Alzheimer Disease (Psychosis)

Struggling with Alzheimer’s-related Psychosis? 

About 25 to 50 percent of people in the US are experiencing Alzheimer’s disease with psychosis symptoms during their illness, however, there is hope on the horizon.

Revive Research Institute is currently conducting Clinical Trial aimed at finding innovative treatments for Alzheimer’s-related psychosis. This trial is crucial in advancing our understanding of the condition and developing effective interventions to improve the quality of life for those affected.

Age

55 to 90 years

Gender

Male and Female

Condition

Alzheimer Psychosis

Current Status

Recruiting

Alzheimer's Disease (Agitation)

Suffering symptoms of agitation in Alzheimer’s disease?

Revive Research Institute is conducting multiple neurology clinical trials in Illinois and Michigan.

Alzheimer’s disease is known to affect about 5.8 million people in the US. It is imperative that we investigate novel therapies that may be able to help people. We are conducting Alzheimer’s-Related Agitation Clinical Trials evaluating the safety and efficacy of an oral investigative medication that may be used to minimize agitation in Alzheimer’s patients.

Age

50 to 90 years

Gender

Male and Female

Condition

Alzheimer's Disease

Current Status

Recruiting

Focal Onset Epilepsy

Tired of dealing with unprovoked seizures?

Revive Research Institute is conducting a double-blind, phase II/III clinical trial to help people living with a debilitating condition called Focal Onset Epilepsy.

The purpose of this research study is to evaluate the safety and efficacy of a novel drug. If you or someone you love has been dealing with unprovoked seizures associated with focal epilepsy, enrolling in epilepsy clinical research studies in Illinois and Michigan may potentially help.

Age

18 to 75 years of age

Gender

Male & Female

Condition

Focal Epilepsy

Current Status

Recruiting

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com